Cellarity
Dr. Carl P. Decicco is a Board Member at Cellarity. Prior to this, they served as the Chief Scientific Officer at Foghorn Therapeutics, Inc from December 2018 to January 2022. Dr. Decicco has also served as the Senior Vice President, Head of Discovery at Bristol-Myers Squibb from May 2013 to November 2018 and as the Senior Vice President, Molecular Sciences at Bristol-Myers Squibb from January 2002 to December 2013.
Carl P. Decicco earned a post-doctoral degree in organic chemistry from Harvard University and another post-doctoral degree in organic chemistry from The University of British Columbia. Carl also attended the University of Guelph.
This person is not in the org chart
This person is not in any offices
Cellarity
1 followers
Founded by Flagship Pioneering, Cellarity is the first company developing medicines through an understanding of cell behaviors. The company’s broad platform harnesses single-cell technologies and machine learning to digitize and quantify cellular behaviors, unravel the network dynamics that govern those behaviors, and generate medicines that can direct them.